Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the montelukast sodium market size evolved in recent years?
In the past few years, the market size for montelukast sodium has seen a significant growth. It is expected to expand from $3.86 billion in 2024 to $4.24 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.9%. The substantial growth during the historic period could be ascribed to the rise in respiratory disorders, an aging global population, escalating levels of air pollution, heightened awareness and education, along with market expansion in emerging economies.
What are the predictions for the montelukast sodium market size in the coming years?
Over the coming years, the montelukast sodium market is projected to experience robust growth, escalating to a value of $6.12 billion by 2029, at a compound annual growth rate (CAGR) of 9.6%. The surge in the projection period can be linked to various factors such as the approval and launch of products, ongoing clinical trials, patent expiration, regulatory amendments, and the prescribing tendencies of physicians. Key trends expected in the forecast span include amplified competition in the generic domain, a transition towards combined therapies, market proliferation in developing regions, concentrated efforts on pediatric applications, and the implementation of digital health solutions.
Get your montelukast sodium market report here!
https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report
What key factors are fueling the growth of the montelukast sodium market?
The escalating rates of asthma are anticipated to drive the expansion of the montelukast sodium market in the future. Asthma, a persistent respiratory disorder characterized by inflammation and narrowing of the airways, leads to recurring episodes of wheezing, difficulty breathing, tightness in the chest, and coughing. Factors such as environmental pollution, allergen exposure, genetic factors, urbanization, lifestyle changes, and respiratory infections have contributed to a rise in asthma cases. Montelukast sodium serves as a leukotriene receptor antagonist in the treatment of asthma, thereby aiding in the control and prevention of asthma symptoms by obstructing the function of leukotrienes, which are responsible for inflammation and narrowing of the airways. For example, data from the American Lung Association, a voluntary health organization based in the U.S, revealed in July 2024 that in 2022, around 44.2 million Americans, which equates to 13.5% of the population, were diagnosed with asthma by a medical professional. Hence, the climbing rates of asthma serve as a catalyst for the growth of the montelukast sodium market.
How is the global montelukast sodium market divided into key segments?
The montelukast sodium market covered in this report is segmented –
1) By Product: Crystal-like, Form-less Or Amorphous
2) By Dosage Form: Tablets, Oral Solutions
3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications
Subsegments:
1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium
2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp
Who are the key firms paving the way for growth in the montelukast sodium market?
Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd
What are the key trends shaping the future of the montelukast sodium market?
Leading businesses in the montelukast sodium market are innovating and launching new drugs, like over-the-counter generic medicine, to offer a more comfortable treatment approach for patients with conditions like asthma and allergic rhinitis. Over-the-counter or OTC generic drugs refer to medicines which can be purchased without any medical prescription, and are typically available at pharmacies and retail outlets. For example, Dr. Reddy’s Laboratories, a pharmaceutical firm based in India, introduced Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg in the United States in July 2022. This particular medicine is formulated to provide temporary relief to nasal and sinus congestion caused by colds or allergies. The drug, equivalent to Allegra-D 24 HR, combines an antihistamine and a nasal decongestant that help reduce symptoms like sneezing, runny nose, itchy eyes and throat. It comes in the packaging of 5, 10 and 15-count and offers a high-quality, budget-friendly remedy to those suffering from upper respiratory discomfort.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16123
What regions are contributing significantly to the growth of the montelukast sodium market?
North America was the largest region in the montelukast sodium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Respiratory Monitoring Devices Global Market Report 2024
Sodium Lauryl Ether Sulfate [SLES] Global Market Report 2024
Sodium Cocoyl Isethionate Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/sodium-cocoyl-isethionate-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
